Washington, DC Bids > Bid Detail
RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for Treatment
| Agency: | |
|---|---|
| Level of Government: | Federal |
| Category: |
|
| Opps ID: | NBD00159210008700212 |
| Posted Date: | Feb 22, 2024 |
| Due Date: | Apr 8, 2024 |
| Source: | https://sam.gov/opp/6adaaeb528... |
Active
Contract Opportunity
Notice ID
RPP-24-03-Treatment
Related Notice
Department/Ind. Agency
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: Feb 21, 2024 07:31 pm EST
- Original Response Date: Apr 08, 2024 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Apr 23, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code:
-
NAICS Code:
-
Place of Performance:
Washington , DCUSA
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of Biomedical Advanced Research and Development Authority (BARDA) entitled "COVID-19 Monoclonal Antibody Therapeutics for Treatment". The full RPP and information on joining the consortium can be accessed through the RRPV website www.rrpv.org. Thank you for your interest in this requirement.
Attachments/Links
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.